Press "Enter" to skip to content

Novel Approaches Seek to Enhance Efficacy of Osimertinib in EGFR+ NSCLC – OncLive

admin 0

Novel Approaches Seek to Enhance Efficacy of Osimertinib in EGFR+ NSCLC  OncLive

Jeffrey M. Clarke, MD, discusses the optimal targeted therapies for the frontline treatment of patients with EGFR-positive NSCLC and sequencing beyond …

“lung cancer” – Google News

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *